BackSeaport Therapeutics Common Stock Overview

Seaport Therapeutics Common Stock EBIT

Explore Seaport Therapeutics Common Stock's ebit with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$65.81M

As of Jun 30, 2026

Annual EBIT (TTM)

N/A

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Seaport Therapeutics Common Stock (SPTX) FAQ

Stockcircle tracks ebit for Seaport Therapeutics Common Stock (SPTX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This EBIT page is built for Seaport Therapeutics Common Stock's historical EBIT trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use EBIT as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main SPTX overview so you can move from this figure to the surrounding analysis quickly.